Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up.
Q3 Medicine
Acta Myologica
Pub Date : 2022-06-30
eCollection Date: 2022-06-01
Amir Dori, Michela Guglieri, Marianna Scutifero, Luigia Passamano, Antonio Trabacca, Luisa Politano
{"title":"Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up.","authors":"Amir Dori, Michela Guglieri, Marianna Scutifero, Luigia Passamano, Antonio Trabacca, Luisa Politano","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>[This retracts the article DOI: 10.36185/2532-1900-058.].</p>","PeriodicalId":35953,"journal":{"name":"Acta Myologica","volume":"41 2","pages":"101"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2f/05/am-2022-101.PMC9299955.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Myologica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
有症状的nmDuchenne携带者能从阿塔鲁仑治疗中获益吗?随访193个月。
[本文撤回文章DOI: 10.36185/2532-1900-058.]。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
